US Patent Issued to AstraZeneca on July 14 for "Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer" (British, Swedish, American Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,444, issued on July 14, was assigned to AstraZeneca AB (Sodertalje, Sweden).

"Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer" was invented by Sten Nilsson-Lill (Sodertalje, Sweden), Kathryn Giblin (Cambridge, Great Britain), Frederick Woolf Goldberg (Cambridge, Great Britain), Jason Grant Kettle (Cambridge, Great Britain), Amber Balazs (Gaithersburg, Md.), Randolph Escobar (Gaithersburg, Md.), Tyler Grebe (Gaithersburg, Md.), Neil Patrick Grimster (Gaithersburg, Md.), Anthony Metrano (Gaithersburg, Md.), Adelphe Mfuh (Gaithersburg, Md.), Lucas Morrill (Gaithersburg, Md.), Li Sha (Gaithersburg, Md.), James Sheppeck (Gaithersburg, Md.), Jason Shie...